Skip to main content

Agile Therapeutics Inc

AGRXDelisted Jun 3, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001261249

Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Agile Therapeutics Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−7 vs. Q3 2021
Shares held
37.7M
+5.87M (+18.5%) vs. Q3 2021
Total value
$18.4M
−$12.2M (−39.8%) vs. Q3 2021
New holders
9
14 more added
Sold out
16
13 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 47 institutions
Q1 2021: 78 institutionsQ2 2021: 71 institutionsQ3 2021: 54 institutionsQ4 2021: 47 institutionsQ1 2022: 39 institutionsQ2 2022: 21 institutionsQ3 2022: 28 institutionsQ4 2022: 27 institutionsQ1 2023: 23 institutionsQ2 2023: 16 institutionsQ3 2023: 17 institutionsQ4 2023: 21 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $18.4M
Q1 2021: $79.6MQ2 2021: $45.7MQ3 2021: $30.5MQ4 2021: $18.4MQ1 2022: $4.04MQ2 2022: $1.28MQ3 2022: $683.0KQ4 2022: $371.5KQ1 2023: $337.2KQ2 2023: $425.8KQ3 2023: $355.2KQ4 2023: $496.2KQ1 2024: $596Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding AGRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$596
Q4 202321$496.2K
Q3 202317$355.2K
Q2 202316$425.8K
Q1 202323$337.2K
Q4 202227$371.5K
Q3 202228$683.0K
Q2 202221$1.28M
Q1 202239$4.04M
Q4 202147$18.4M
Q3 202154$30.5M
Q2 202171$45.7M
Q1 202178$79.6M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Agile Therapeutics Inc; share changes are against Q3 2021.

Institutions holding AGRX in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC21,294,485$10.4M0.16%+5,374,560+33.8%Added
Vanguard Group Inc4,494,704$2.19M0.00%+389,856+9.5%Added
Investor AB3,510,189$1.72M0.04%00.0%Unchanged
D. E. Shaw & Co., Inc.2,161,006$1.05M0.00%+1,839,143+571.4%Added
BlackRock Inc.1,507,654$736.0K0.00%+37,394+2.5%Added
Millennium Management LLC938,561$458.0K0.00%−1,418−0.2%Reduced
Gsa Capital Partners LLP733,685$358.0K0.04%+147,194+25.1%Added
Geode Capital Management, LLC701,751$342.0K0.00%00.0%Unchanged
Needham Investment Management LLC350,000$171.0K0.02%−385,000−52.4%Reduced
State Street Corp290,345$142.0K0.00%00.0%Unchanged
Virtu Financial LLC237,642$116.0K0.01%+210,370+771.4%Added
Citadel Advisors LLC170,978$84.0K0.00%+137,995+418.4%Added
Renaissance Technologies LLC162,900$80.0K0.00%+126,015+341.6%Added
First Midwest Bank Trust Division160,980$79.0K0.01%−174,755−52.1%Reduced
Northern Trust Corp144,816$71.0K0.00%−101,904−41.3%Reduced
Susquehanna International Group, LLP101,796$50.0K0.00%+8,852+9.5%Added
Grimes & Company, Inc.84,378$41.0K0.00%−15,366−15.4%Reduced
Morgan Stanley80,244$39.0K0.00%−440,363−84.6%Reduced
Jane Street Group, LLC75,454$37.0K0.00%+75,454New
Advisor Group Holdings, Inc.72,950$36.0K0.00%+4,200+6.1%Added
Price T Rowe Associates Inc42,200$21.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp40,667$20.0K0.00%00.0%Unchanged
HBK Sorce Advisory LLC35,000$17.0K0.00%00.0%Unchanged
Group One Trading, L.P.31,277$15.0K0.00%−13,800−30.6%Reduced
Goldman Sachs Group Inc24,153$12.0K0.00%+24,153New
LPL Financial LLC20,244$10.0K0.00%−6,100−23.2%Reduced
Founders Capital Management20,000$10.0K0.01%+15,000+300.0%Added
Advisory Services Network, LLC21,000$10.0K0.00%+21,000New
Tower Research Capital LLC (TRC)18,290$9.00K0.00%+18,290New
Victory Capital Management Inc14,481$7.00K0.00%+2,902+25.1%Added
Royal Bank of Canada11,027$6.00K0.00%−799,197−98.6%Reduced
HRT Financial LP13,620$6.00K0.00%−97,473−87.7%Reduced
Simplex Trading, LLC11,554$5.00K0.00%−8,257−41.7%Reduced
Creative Planning10,000$5.00K0.00%00.0%Unchanged
Centric Wealth Management10,000$5.00K0.00%00.0%Unchanged
Parsec Financial Management, Inc.11,000$5.00K0.00%00.0%Unchanged
Janney Montgomery Scott LLC10,000$5.00K0.00%+10,000New
Citigroup Inc7,432$4.00K0.00%00.0%Unchanged
UBS Group AG4,634$2.00K0.00%+3,874+509.7%Added
Reilly Financial Advisors, LLC3,111$2.00K0.00%+3,111New
Captrust Financial Advisors3,500$2.00K0.00%+3,500New
CWM, LLC5,000$2.00K0.00%+5,000New
Aquatic Capital Management LLC4,000$2.00K0.00%+4,000New
Wells Fargo & Company2,595$1.00K0.00%+133+5.4%Added
BNP Paribas Arbitrage, SA1,850$9030.00%−80−4.1%Reduced
JPMorgan Chase & Co110$00.00%−4,470−97.6%Reduced
NEXT Financial Group, Inc200$00.00%00.0%Unchanged
Ergoteles LLC0$00.00%−211,611−100.0%Sold out
Summit Global Investments0$00.00%−126,000−100.0%Sold out
Dumont & Blake Investment Advisors LLC0$00.00%−70,000−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−29,000−100.0%Sold out
Raymond James & Associates0$00.00%−26,500−100.0%Sold out
Principal Financial Group Inc0$00.00%−17,409−100.0%Sold out
Kalos Management, Inc.0$00.00%−17,749−100.0%Sold out
Barclays PLC0$00.00%−11,588−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−11,138−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−10,110−100.0%Sold out
Bank of America Corp0$00.00%−7,054−100.0%Sold out
IFP Advisors, Inc0$00.00%−5,000−100.0%Sold out
Atlas Private Wealth Advisors0$00.00%−2,500−100.0%Sold out
FMR LLC0$00.00%−10−100.0%Sold out
Harbour Investments, Inc.0$00.00%−75−100.0%Sold out
Jacobi Capital Management LLC0$00.00%−500−100.0%Sold out